Outcome of influenza infection: effect of site of initial infection and heterotypic immunity.
about
Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primatesAnti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitorsMucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model.Heterosubtypic immunity to influenza A virus: where do we stand?Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemicGamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania majorHeterotypic immunity to influenza in ferrets.Influence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccinesSuppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice.A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in agingA viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenzaControl of mucosal virus infection by influenza nucleoprotein-specific CD8+ cytotoxic T lymphocytesEnteric immunization of mice against influenza with recombinant vacciniaThe contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection.Development of a murine nose-only inhalation model of influenza: comparison of disease caused by instilled and inhaled A/PR/8/34.Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge.Immunoglobulin A mediation of murine nasal anti-influenza virus immunity.Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal, inoculation.Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infectionInduction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.Kinetics of pulmonary immune cells, antibody responses and their correlations with the viral clearance of influenza A fatal infection in mice.Towards a quantitative understanding of the within-host dynamics of influenza A infections.Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant.Salivary Blockade Protects the Lower Respiratory Tract of Mice from Lethal Influenza Virus Infection.Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses.Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus.The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses.
P2860
Q27348520-7C1B535F-E6EC-4EFC-9557-89620C1914A4Q28378984-14169BA0-FBC4-43C3-9994-CB408836CD90Q30360144-F0527BD7-327E-4756-A12C-9324731675FEQ30370995-FF440C2C-7ADC-42F1-B5BD-DD7AD25EC2A7Q30391993-70CB6689-67B9-462A-A901-18DCB44BD979Q33805562-3EAF7575-A1DF-4EDE-A2BE-073C5A8FFCECQ33834576-B4531AE8-AD66-4D16-8663-043FAF9F5661Q33899666-43B6EA43-1D5A-4265-8089-A6C52F5594BCQ33906922-FFE897A9-41E0-4894-ABC8-F181E922928AQ34131862-BEE38436-C176-4BC6-A176-BBA4F0E56E97Q34416399-15D2B6F9-89AD-4098-AC5B-EC9AF557783DQ35661214-DCCD23D7-4519-4C60-9824-94BF841D7242Q35861566-DFE978CF-0650-4A25-BD2B-AAE366B64987Q35868774-27277D70-40DB-404F-8091-19DCBAB435DCQ35880528-1D496C26-6327-4407-A048-776D889FC478Q35900617-BF4FE226-BA78-4967-AFE2-E1FE73CE2CDBQ35943771-4B6BCF2B-49E7-4218-AE4E-DBC3583BF9A8Q36159259-EF8EC5DB-E78C-453B-94B4-62D87908E38FQ36231145-CA4EC5BF-4972-4A05-9A86-E94E08428F18Q36684724-E958E233-F7E4-4C78-BD3C-3A034126EC87Q36760233-7CFC7AA3-AD00-4FFE-A34E-E126402BC107Q37076666-1EBAD80F-FA3D-424A-A2AD-B0898A7F74C7Q37451865-D1EFBCB3-5DD1-4519-A01C-0EBD496BFE76Q37703101-6A13BAC2-E5EE-42C4-8F70-01AE28B90976Q39643221-A2BBAD93-FBBD-4922-B474-3F44FD108D09Q39770621-1CBA4A15-8F96-4715-B2BB-9E2D1DFCF0FCQ40226257-EF248DA6-1CDC-4C6E-ADDA-84EEEB328976Q41865771-7FB4AA10-4186-4E70-9E07-3F3B4DBBFC67Q45733156-9390F481-15AD-4A04-903A-E6A1E32957F9Q45754067-50A6A8CC-8397-4AE8-9171-287E887E1B46
P2860
Outcome of influenza infection: effect of site of initial infection and heterotypic immunity.
description
1980 nî lūn-bûn
@nan
1980 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Outcome of influenza infection ...... tion and heterotypic immunity.
@ast
Outcome of influenza infection ...... tion and heterotypic immunity.
@en
type
label
Outcome of influenza infection ...... tion and heterotypic immunity.
@ast
Outcome of influenza infection ...... tion and heterotypic immunity.
@en
prefLabel
Outcome of influenza infection ...... tion and heterotypic immunity.
@ast
Outcome of influenza infection ...... tion and heterotypic immunity.
@en
P2093
P2860
P1476
Outcome of influenza infection ...... tion and heterotypic immunity.
@en
P2093
P2860
P304
P407
P577
1980-08-01T00:00:00Z